Literature DB >> 9658082

cis Elements required for high-level expression of unspliced Gag-containing message in Moloney murine leukemia virus.

M Oshima1, T Odawara, K Hanaki, H Igarashi, H Yoshikura.   

Abstract

The 441-nucleotide (nt) region (nt 5325 to 5766) around the splice acceptor (SA) site (nt 5491) was found to be necessary for high-level expression of gag-containing unspliced RNA of Moloney murine leukemia virus (M. Oshima, T. Odawara, T. Matano, H. Sakahira, K. Kuchino, A. Iwamoto, and H. Yoshikura, J. Virol. 70:2286-2295, 1996). Detailed genetic dissection of the 441-nt region revealed that the 5'-end 64 nt (nt 5325 to 5389) were necessary for high-level expression of the unspliced RNA when the spliced RNA was not produced, while the 3'-side 301 nt (nt 5466 to 5766) containing the SA site were necessary for producing spliced RNA. When the spliced RNA was produced, the unspliced RNA could be expressed at a high level even when the 5'-end 64 nt were absent. Probably the virus sequence ensuring the splicing could produce an RNA structure able to compensate for the function of the 5'-end 64-nt region responsible for the expression of the unspliced RNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658082      PMCID: PMC109795     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.

Authors:  X B Lu; J Heimer; D Rekosh; M L Hammarskjöld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

3.  Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.

Authors:  M T McNally; R R Gontarek; K Beemon
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

4.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

5.  Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

Authors:  R K Saiki; T L Bugawan; G T Horn; K B Mullis; H A Erlich
Journal:  Nature       Date:  1986 Nov 13-19       Impact factor: 49.962

6.  Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression.

Authors:  A W Cochrane; K S Jones; S Beidas; P J Dillon; A M Skalka; C A Rosen
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing.

Authors:  M T McNally; K Beemon
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

9.  Analysis of Moloney murine leukemia virus revertants mutated at the gag-pol junction.

Authors:  T Odawara; H Yoshikura; M Ohshima; T Tanaka; D S Jones; F Nemoto; Y Kuchino; A Iwamoto
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome.

Authors:  H S Olsen; A W Cochrane; C Rosen
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

View more
  3 in total

1.  R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs.

Authors:  A M Trubetskoy; S A Okenquist; J Lenz
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 2.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  The retrovirus RNA trafficking granule: from birth to maturity.

Authors:  Alan W Cochrane; Mark T McNally; Andrew J Mouland
Journal:  Retrovirology       Date:  2006-03-17       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.